R Pollack, I Raz,
SD Wiviott, EL Goodrich… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE The cardiorenal benefits of adding sodium–glucose cotransporter 2 (SGLT2)
inhibitor therapy for patients on insulin, particularly those on intensive regimens that include …